MARKET INSIGHTS

ZTOX Insights

AI-assisted articles on quarterly results, exchange filings, and earnings calls — tied to the companies you follow.

8 articles published

All Market Updates (8967) Corporate announcement (8258) Financial Results (3178) Earnings conference call (344) Chartink scans (124) BSE filings (119) NSE filings (72) TECHNOCRAFT INDUSTRIES (INDIA) (52) Live gainers (47) Network People Services Technologies (41)

Results for “ZYDUSLIFE” · in Corporate announcement — Clear filters

ZYDUSLIFE

Jun 4, 2026 1 min read

Market Updates Corporate announcement

Zydus Lifesciences (ZYDUSLIFE): Company Update

Company Update Receipt of Warning Letter from USFDA for Baddi facility Receipt of Warning Letter from USFDA for Baddi facility Receipt of Warning Letter from USFDA for Baddi facility

Read article

ZYDUSLIFE

Jun 4, 2026 1 min read

Market Updates Corporate announcement

Zydus Lifesciences (ZYDUSLIFE): Company Update

Company Update Receipt of Warning Letter from USFDA for Baddi facility Receipt of Warning Letter from USFDA for Baddi facility Receipt of Warning Letter from USFDA for Baddi facility

Read article

ZYDUSLIFE

Jun 4, 2026 1 min read

Market Updates Corporate announcement

Zydus Lifesciences (ZYDUSLIFE): Buyback

Buyback Zydus Lifesciences Limited has informed the Exchange about Buyback Zydus Lifesciences Limited has informed the Exchange about Buyback Zydus Lifesciences Limited has informed the Exchange about Buyback

Read article

ZYDUSLIFE

Jun 4, 2026 1 min read

Market Updates Corporate announcement

Zydus Lifesciences Announces Share Buyback via NSE Filing

Zydus Lifesciences Limited (NSE: ZYDUSLIFE) has notified the exchanges about a share buyback program. The announcement signals the pharma major's intent to return capital to shareholders.

Read article

ZYDUSLIFE

Jun 4, 2026 1 min read

Market Updates Corporate announcement

Zydus Lifesciences (ZYDUSLIFE): Buyback

Read article

ZYDUSLIFE

Jun 4, 2026 1 min read

Market Updates Corporate announcement

Zydus Lifesciences (ZYDUSLIFE): Company Update

Company Update Zydus Therapeutics'' New Drug Application (NDA) for Saroglitazar to treat Primary Biliary Cholangitis (PBC) granted Priority Review by the US FDA. Zydus Therapeutics'' New Drug Application (NDA) for Saroglitazar to treat Primary Biliary Cholangitis (PBC) granted Priority Review by the US FDA. Zydus Therapeutics'' New Drug Application (NDA) for Saroglitazar to treat Primary Biliary Cholangitis (PBC) granted Priority Review by the US FDA.

Read article

ZYDUSLIFE

Jun 4, 2026 1 min read

Market Updates Corporate announcement

Zydus Lifesciences (ZYDUSLIFE): Press Release

Press Release Zydus Lifesciences Limited has informed the Exchange regarding a press release dated May 28, 2026, titled "Zydus Therapeutics New Drug Application (NDA) for Saroglitazar to treat Primary Biliary Cholangitis (PBC) granted Priority Review by the US FDA". Zydus Lifesciences Limited has informed the Exchange regarding a press release dated May 28, 2026, titled "Zydus Therapeutics New Drug Application (NDA) for Saroglitazar to treat Primary Biliary Cholangitis (PBC) granted Priority

Read article

ZYDUSLIFE

Jun 3, 2026 1 min read

Market Updates Corporate announcement

Zydus Lifesciences Subsidiary Gets CGST Demand Order from Ahmedabad Authority

Zydus VTEC Limited, the wholly owned subsidiary of Zydus Lifesciences, has received a Demand Order-In-Original from the Deputy Commissioner of CGST & Central Excise based in Ahmedabad North Commissionerate.

Read article

Plans built for every investor

TRUSTED BY INVESTORS

Track Indian stocks with ZTOX AI

NSE & BSE filings, quarterly results, insider trades, and smart volume alerts — delivered on WhatsApp or Telegram. No separate app to install.

"ZTOX alerts helped me catch a multi-bagger stock last quarter. The insider deals notifications are absolutely game-changing for retail investors."

Rahul K., Active Trader